Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rui Ma
Observed name:
R. Ma
Institutions:
Qinghai University,
Qinghai University Affiliated Hospital,
Xijing Hospital,
Air Force Medical University
Observed institutions:
Qinghai University,
Qinghai University Affiliated Hospital,
Xijing Hospital,
Liaoning Cancer Hospital & Institute,
Air Force Medical University
ORCID:
0000-0003-2111-5619
Observed ORCID:
0000-0003-2111-5619
OpenAlex ID:
A5100771823
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
2023
·
Shun Lu
, Jianying Zhou
, et al.
·
The Lancet Respiratory Medicine
·
96
Consensus on the lung cancer management after third-generation EGFR-TKI resistance
2024
·
Qing Zhou
, Hongyun Zhao
, et al.
·
The Lancet Regional Health - Western Pacific
·
59
PDF
Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b Study
2022
·
Yuankai Shi
, Baolan Li
, et al.
·
Journal of Thoracic Oncology
·
36
PDF
Role and mechanism of miR-4778-3p and its targets NR2C2 and Med19 in cervical cancer radioresistance
2018
·
Ying Zhang
, Pei Li
, et al.
·
Biochemical and Biophysical Research Communications
·
25
Periodontal disease and risk of Alzheimer's disease: A two‐sample Mendelian randomization
2024
·
Conglei Hu
, Hui Li
, et al.
·
Brain and Behavior
·
13
PDF
Causality between six psychiatric disorders and digestive tract cancers risk: a two-sample Mendelian randomization study
2024
·
Qi Fu
, Linghui Li
, et al.
·
Scientific Reports
·
2
Ketone Body Metabolism in Cancer-Associated Fibroblasts and FSTL3 as Prognostic and Therapeutic Determinants of Chemoradiotherapy Response in Cervical Cancer
2026
·
Hua Yang
, Litian Ma
, et al.
·
Frontiers in Bioscience-Landmark
PDF
Expert Consensus on the Standardized Diagnosis, Treatment, and Management of Cancer in High‐Altitude Regions of China
2026
·
Yiqun Li
, Feng Li
, et al.
·
Cancer Innovation
PDF
1871P Tislelizumab (TIS) treatment beyond progression in advanced sq-NSCLC after 1L chemoimmunotherapy: Results from randomized, phase III RATIONALE-307 study
2025
·
Z. Wang
, X. Yu
, et al.
·
Annals of Oncology
[Influence of Streptococcus mutans luxS gene on polysaccharide matrix metabolism].
2011
·
Qian Wang
, Zi-sheng Tang
, et al.
·
PubMed
Show more works
View as search
Works count:
10
Citation count:
231
H-index:
5
I10-index:
5
Year
Topic
Type